Application of Citrate Dialysate in Chronic Haemodialysis
NCT ID: NCT01532297
Last Updated: 2014-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
95 participants
INTERVENTIONAL
2011-10-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes
NCT00718289
Citrate Dialysate in Online Hemodialfiltration
NCT05280106
Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation
NCT03577249
Substitution of Acetate by Citrate in the Bicarbonate Based Hemodialysis
NCT02745340
Observational Study of Citrate Based Dialysis in Pediatric Patients Receiving Hemodialysis
NCT01590550
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HD treated with standard dialysate
Standard dialysate (StDi)
Use during chronic dialysis 3x/week
post-dilution oHDF with standard dialysate
Standard dialysate (StDi)
Use during chronic dialysis 3x/week
pre-dilution oHDF with citrate dialysate
Citrate dialysate (CiDi)
Use during chronic dialysis 3x/week
HD treated with citrate dialysate
Citrate dialysate (CiDi)
Use during chronic dialysis 3x/week
post-dilution oHDF with citrate dialysate
Citrate dialysate (CiDi)
Use during chronic dialysis 3x/week
pre-dilution oHDF with standard dialysate
Standard dialysate (StDi)
Use during chronic dialysis 3x/week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Citrate dialysate (CiDi)
Use during chronic dialysis 3x/week
Standard dialysate (StDi)
Use during chronic dialysis 3x/week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients of either sex aged ≥ 18 years
* stable chronic dialysis patients undergoing a 3x/week high-flux dialysis for at least three months
* patients without planned or predictable changes within diet, anticoagulation and medication regimen
Exclusion Criteria
* planned surgeries or hospital stay within the next 9 weeks
* use of catheter as vascular access for dialysis
* severe comorbidities not allowing to follow the study protocol
* concomitant participation in another study
* previous participation in this study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fresenius Medical Care Deutschland GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Schmitz, Dr.
Role: PRINCIPAL_INVESTIGATOR
Städt. Klinikum Solingen gemeinnützige GmbH Klinik für Nephrologie und Allgemeine Innere Medizin
Olaf Loke, Dr.
Role: PRINCIPAL_INVESTIGATOR
Nephrologische Gemeinschaftspraxis
Klaus Kalb, Dr.
Role: PRINCIPAL_INVESTIGATOR
Märkische Dialysezentren GmbH
Bernhard Fach, Dr.
Role: PRINCIPAL_INVESTIGATOR
PHV Dialysezentrum
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Märkische Dialysezentren GmbH
Lüdenscheid, , Germany
Nephrologische Gemeinschaftspraxis
Lüdenscheid, , Germany
Städt. Klinikum Solingen gemeinnützige GmbH Klinik für Nephrologie und Allgemeine Innere Medizin
Solingen, , Germany
PHV Dialysezentrum
Wetzlar, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Natale P, Ju A, Strippoli GF, Craig JC, Saglimbene VM, Unruh ML, Stallone G, Jaure A. Interventions for fatigue in people with kidney failure requiring dialysis. Cochrane Database Syst Rev. 2023 Aug 31;8(8):CD013074. doi: 10.1002/14651858.CD013074.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
There is no secondary ID
Identifier Type: -
Identifier Source: secondary_id
HD-CiDi-01-D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.